← Leaderboards
James Bruce Bussel
Weill Medical College Of Cornell Univ
$3,000,788
Attributed
$3,000,788
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $417.9K · FY2005–14$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,000,788 · 4
By mechanism
U01$2,117,011 · 1
U34$830,574 · 1
M01$53,203 · 2
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Jeffrey C Laurence$3,792,970
- Kristen M Marks$2,115,537
- Marc E Weksler$1,856,373
- Suchitra S Acharya$329,576
- Richard T Silver$0
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsHuman SubjectHemostatic AgentsResourcesSiteProtocols DocumentationRecruitment ActivityEligibility DeterminationPresbyterian ChurchNew YorkParticipantMonoclonal AntibodyHospitalsHemostatic FunctionMedicineNeutropeniaDiagnosisCytokineLaboratoriesConduct Clinical TrialsGrowth FactorEnsureHealth PersonnelInformed Consent
Grant awards (13)
Determining Optimum Medical Therapy for ITP$412,679
U34 · FY2014 · HL · contact PI
Determining Optimum Medical Therapy for ITP$417,895
U34 · FY2013 · HL · contact PI
Novel Therapies in Hemostasis and Transfusion$183,750
U01 · FY2012 · HL · contact PI
Novel Therapies in Hemostasis and Transfusion$20,310
U01 · FY2010 · HL · contact PI
Novel Therapies in Hemostasis and Transfusion$210,000
U01 · FY2009 · HL · contact PI
Novel Therapies in Hemostasis and Transfusion$210,000
U01 · FY2007 · HL · contact PI
Novel Therapies in Hemostasis and Transfusion Medicine$292,951
U01 · FY2006 · HL · contact PI
Novel Therapies in Hemostasis and Transfusion Medicine$300,000
U01 · FY2005 · HL
RITUXAN COMPARISON STANDARD VS COMBINATION WITH CVP IN ITP$36,440
M01 · FY2005 · RR
OPEN LABEL, PHASE I/II TRIAL OF RITUXIMAB FOR CHRONIC, SEVERE, IDIOPATHIC THROM$16,763
M01 · FY2005 · RR
Novel Therapies in Hemostasis and Transfusion Medicine$300,000
U01 · FY2004 · HL
Novel Therapies in Hemostasis and Transfusion Medicine$300,000
U01 · FY2003 · HL
Novel Therapies in Hemostasis and Transfusion Medicine$300,000
U01 · FY2002 · HL